Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia
- PMID:18813041
- DOI: 10.1097/ALN.0b013e3181862a0d
Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia
Abstract
Background: Persistent high creatine kinase (CK) levels may reflect underlying subclinical myopathies. In most cases, pathogenesis is unknown and clinical management is unclear. Though clinically asymptomatic, these subjects are potentially susceptible to malignant hyperthermia.
Methods: The authors analyzed 37 subjects with persistent elevation of CK without significant weakness or other neurologic symptoms. Neurologic examination was performed according to manual muscle testing. Muscle biopsy and the in vitro contracture test were performed in all subjects.
Results: Twenty-three subjects (51.1%) were completely asymptomatic. The others had minor symptoms such as occasional cramps (11 subjects, 24.4%), fatigue (5 subjects, 11.1%), a combination of cramps and fatigue (5 subjects, 11.1%), and muscle pain (1 case, 2.2%). Muscle biopsy enabled precise diagnosis in 3 cases and was normal in 3 cases. The more frequent changes were variation in fiber size (31.1%), a combination of nuclear internalization and variation in fiber size (26.6%), nuclear internalization (6.6%), minor mitochondrial changes (4.4%), and neurogenic atrophy (4.4%). Immunocytochemical analysis was normal in all patients. In vitro contracture testing detected one malignant hyperthermia-susceptible and one malignant hyperthermia-equivocal subject.
Conclusions: The evidence of malignant hyperthermia susceptibility by in vitro contracture test seems to be relatively infrequent among subjects with idiopathic hyperCKemia, but the incidence of true malignant hyperthermia in idiopathic hyperCKemia is unknown. Muscle biopsy should be considered a useful, though not very sensitive, diagnostic tool in idiopathic hyperCKemia, because it enables potentially treatable disorders, such as inflammatory myopathies, to be discovered. No uniform morphologic finding typical of idiopathic hyperCKemia or malignant hyperthermia susceptibility was identified by muscle biopsy.
Similar articles
- Asymptomatic or minimally symptomatic hyperCKemia: histopathologic correlates.Dabby R, Sadeh M, Herman O, Berger E, Watemberg N, Hayek S, Jossiphov J, Nevo Y.Dabby R, et al.Isr Med Assoc J. 2006 Feb;8(2):110-3.Isr Med Assoc J. 2006.PMID:16544734
- [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].Urwyler A, Censier K, Seeberger MD, Drewe J, Rothenbühler JM, Frei F.Urwyler A, et al.Schweiz Med Wochenschr. 1991 Apr 20;121(16):566-71.Schweiz Med Wochenschr. 1991.PMID:2042040German.
- Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.Weisshorn R, Wappler F, Fiege M, Gerbershagen MU, Kolodzie K, Alberts P, Horn EP, Schulte Am Esch J.Weisshorn R, et al.J Clin Anesth. 2004 Aug;16(5):353-7. doi: 10.1016/j.jclinane.2003.09.014.J Clin Anesth. 2004.PMID:15374556
- Central core disease.Jungbluth H.Jungbluth H.Orphanet J Rare Dis. 2007 May 15;2:25. doi: 10.1186/1750-1172-2-25.Orphanet J Rare Dis. 2007.PMID:17504518Free PMC article.Review.
- Core myopathies and risk of malignant hyperthermia.Klingler W, Rueffert H, Lehmann-Horn F, Girard T, Hopkins PM.Klingler W, et al.Anesth Analg. 2009 Oct;109(4):1167-73. doi: 10.1213/ANE.0b013e3181b5ae2d.Anesth Analg. 2009.PMID:19762745Review.
Cited by
- Next-generation sequencing approach to hyperCKemia: A 2-year cohort study.Rubegni A, Malandrini A, Dosi C, Astrea G, Baldacci J, Battisti C, Bertocci G, Donati MA, Dotti MT, Federico A, Giannini F, Grosso S, Guerrini R, Lenzi S, Maioli MA, Melani F, Mercuri E, Sacchini M, Salvatore S, Siciliano G, Tolomeo D, Tonin P, Volpi N, Santorelli FM, Cassandrini D.Rubegni A, et al.Neurol Genet. 2019 Aug 16;5(5):e352. doi: 10.1212/NXG.0000000000000352. eCollection 2019 Oct.Neurol Genet. 2019.PMID:31517061Free PMC article.
- Malignant hyperthermia: a review.Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K.Rosenberg H, et al.Orphanet J Rare Dis. 2015 Aug 4;10:93. doi: 10.1186/s13023-015-0310-1.Orphanet J Rare Dis. 2015.PMID:26238698Free PMC article.Review.
- Approach to asymptomatic creatine kinase elevation.Moghadam-Kia S, Oddis CV, Aggarwal R.Moghadam-Kia S, et al.Cleve Clin J Med. 2016 Jan;83(1):37-42. doi: 10.3949/ccjm.83a.14120.Cleve Clin J Med. 2016.PMID:26760521Free PMC article.Review.
- Alpha-sarcoglycanopathy presenting as myalgia and hyperCKemia in two adults with a long-term follow-up. Case reports.Dosi C, Rubegni A, Cassandrini D, Malandrini A, Maggi L, Donati MA, Santorelli FM.Dosi C, et al.Acta Myol. 2020 Dec 1;39(4):218-221. doi: 10.36185/2532-1900-025. eCollection 2020 Dec.Acta Myol. 2020.PMID:33458577Free PMC article.
- Correlation of phenotype with genotype and protein structure in RYR1-related disorders.Todd JJ, Sagar V, Lawal TA, Allen C, Razaqyar MS, Shelton MS, Chrismer IC, Zhang X, Cosgrove MM, Kuo A, Vasavada R, Jain MS, Waite M, Rajapakse D, Witherspoon JW, Wistow G, Meilleur KG.Todd JJ, et al.J Neurol. 2018 Nov;265(11):2506-2524. doi: 10.1007/s00415-018-9033-2. Epub 2018 Aug 28.J Neurol. 2018.PMID:30155738Free PMC article.Clinical Trial.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Research Materials